JAN 16, 2019 9:00 AM PST

Predicting Response to Intravesical Immunotherapy with BCG

Speaker
  • Professor of Urology and Director of Urologic Oncology Fellowship, M.D. Anderson Cancer Center
    Biography
      Dr Ashish M. Kamat is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at M.D. Anderson Cancer Center, and a graduate of the AUA Leadership Program. Dr Kamat's expertise is in multidisciplinary management of urologic cancers with an emphasis bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). While he is a busy surgeon, he maintains an active research portfolio to improve the care of patients. Dr Kamat's efforts are directed towards identifying predictors of response to therapy - especially immunotherapy - as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE. He has authored over 200 publications, editorials & book chapters in prestigious journals; he is listed in'Who's Who in Medicine' and 'Best Doctors in America' and has won the Compassionate Doctor Award from patient groups. He is an exceptional educator nominated twice for the Robert M. Chamberlain Distinguished Mentor Award and has been invited as a visiting professor to several universities across the world. Dr Kamat is also Co President,International Bladder Cancer Network, Chair, Bladder Cancer Think Tank (2015), Chair, Bladder Cancer Task Force for SITC, actively participates in various global urologic efforts, and serves on the board of regional and national societies for Urology.

    Abstract

    DATE: January 16th, 2019

    TIME: 9:00AM PST, 12:00PM EST

    Dr. Kamat will present his clinical experience using molecular markers, in addition to the standard of care, to examine patient outcomes in the BCG response monitoring scenario.

    Learning Objectives:

    • Review of Bladder Cancer case studies to understand the use of BCG in bladder cancer subtypes
    • Understand BCG tolerance, patient response, and use of UroVysion

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JAN 16, 2019 9:00 AM PST

    Predicting Response to Intravesical Immunotherapy with BCG


    Specialty

    Molecular Biology

    Cancer Research

    Genetics

    Laboratory Testing

    Clinical Diagnostics

    Molecular Diagnostics

    Cell Biology

    Clinical Research

    Cancer Diagnostics

    Immunology

    Diagnostics

    Medicine

    Cancer Therapeutics

    Microbiology

    Biotechnology

    Geography

    North America70%

    Asia13%

    Europe11%

    Africa4%

    South America1%

    Registration Source

    Website Visitors54%

    Email Promotions32%

    WAVE Newsletter Promotion8%

    Social Media Promotions3%

    Trending Newsletter Promotion1%

    Website Banners1%

    Other1%

    Job Title

    Medical Laboratory Technician17%

    Facility/Department Manager11%

    Student9%

    Lab Management8%

    Clinical Laboratory Scientist8%

    Educator/Faculty7%

    Executive7%

    Research Scientist7%

    Genetic Counselor7%

    Scientist6%

    Medical Doctor/Specialist6%

    Marketing/Sales3%

    Post Doc2%

    Consultant2%

    Microbiologist1%

    Organization

    Hospital20%

    Clinical Laboratory17%

    Academic Institution15%

    Biotech Company7%

    Independent Laboratories5%

    Medical Center4%

    Research Institute3%

    Medical Device Company3%

    Life Science Company3%

    Medical School3%

    Pharmaceutical Company2%

    Diagnostic Company2%

    Ambulatory Care2%

    Government1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more